NCT05139797View on ClinicalTrials.gov

Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

November 18, 2021

Primary Completion Date

January 1, 2026

Study Completion Date

June 1, 2027

Conditions
Cardiac Amyloidosis
Interventions
OTHER

EchoNet-LVH screening for cardiac amyloidosis

An AI algorithm identifies LVH, low voltage, and high suspicion for cardiac amyloidosis. The intervention is the suspicion score. Patients with high suspicion score will be referred to specialty clinic for standard of care evaluation, screening, and treatment as determined by physicians.

Trial Locations (1)

90048

RECRUITING

Cedars-Sinai Medical Centre (Los Angeles), Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER